ERBB2 and neoplasm: We may predict additional positive nodes in ALND accordingly the number of positive nodes in SLNB, tumor-related factors, and treatment response.In this study we found that in the case of SLNB 1 + positivity, it was observed that all patients in the HER-2-positive and triple-negative patient groups had no additional nodes positive at ALND.